MannKind | 资产



Assets 更改 日
Adma Biologics USD 488.68M 98.06M 2024-12
Dynavax Technologies USD 986.26M 75.73M 2024-12
Eli Lilly USD 78.71B 3.11B 2024-12
Halozyme Therapeutics USD 2.06B 54.55M 2024-12
Insmed USD 2.03B 27.74M 2024-12
MacroGenics USD 261.65M 2.84M 2024-12
MannKind USD 393.84M 70.36M 2024-12
Merck USD 117.11B 426M 2024-12
Novo Nordisk DKK 397.44B 28.06B 2024-09
Pfizer USD 213.4B 6.08B 2024-12
Sanofi 129.76B 3.29B 2024-06
Xencor USD 951.94M 31.69M 2024-12



MannKind 资产 - 当前值，历史数据，预测，统计，图表和经济日历 - Apr 2025.